Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Represented By The SecrfiledCriticalUs Gov Represented By The Secr
Priority claimed from NZ325561Aexternal-prioritypatent/NZ325561A/en
Publication of NZ335409ApublicationCriticalpatent/NZ335409A/en
A biologically active agent such as a peptide or a protein and a blend of uncapped and end-capped biodegradable poly(lactide/glycolide) are used in the manufacture of a controlled release microcapsule pharmaceutical formulation for burst-free, sustained, programmable release of over duration from 1-100 days following administration via parenteral, topical, oral, nasal, transdermal, rectal or vaginal routes.
NZ335409A1996-01-241996-11-18Use of a burst free controlled release poly(lactide/glycolide) microcapsule pharmaceutical formulation
NZ335409A
(en)
Pharmaceutical composition containing an active ingredient and poly(lactide/glycolide) microcapsules which is a burst free controlled release formulation
Compositions containing a peptide and polylactic acid glycolic acid suitable for the preparation of subcutaneous implants with an extended release period